Novel Analgesics

Vitaly Gordin; Daniel Morgan; Michael Mueller; Alba Guevara; Yuri Gordin

doi:10.1007/978-3-030-12281-2_25

Novel Analgesics

Vitaly Gordin
, Daniel Morgan
, Michael Mueller
, Alba Guevara
, Yuri Gordin

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Abstract

Pain is the most frequent complaint and reason why patients visit medical providers. While opioid analgesics remain the mainstay of pain control in the acute setting, the benefits in chronic pain have been questioned. Overprescribing of opioid for acute and semi-acute pain has led to dependence in millions of Americans. It has been also responsible, at least partially, for opioid abuse and a closely related abuse of heroin. In the light of the current opioid epidemic, tremendous efforts have been made to develop new opioid ligands which are void of euphoric effects and medications whose action is targeting various pain mechanisms.

Original language	English (US)
Title of host publication	Deer's Treatment of Pain
Subtitle of host publication	An Illustrated Guide for Practitioners
Publisher	Springer Science+Business Media
Pages	205-216
Number of pages	12
ISBN (Electronic)	9783030122812
ISBN (Print)	9783030122805
DOIs	https://doi.org/10.1007/978-3-030-12281-2_25
State	Published - Jan 1 2019

All Science Journal Classification (ASJC) codes

General Medicine
General Neuroscience

Access to Document

10.1007/978-3-030-12281-2_25

Cite this

@inbook{413d10b6359b4817821261c14c5ea652,

title = "Novel Analgesics",

abstract = "Pain is the most frequent complaint and reason why patients visit medical providers. While opioid analgesics remain the mainstay of pain control in the acute setting, the benefits in chronic pain have been questioned. Overprescribing of opioid for acute and semi-acute pain has led to dependence in millions of Americans. It has been also responsible, at least partially, for opioid abuse and a closely related abuse of heroin. In the light of the current opioid epidemic, tremendous efforts have been made to develop new opioid ligands which are void of euphoric effects and medications whose action is targeting various pain mechanisms.",

author = "Vitaly Gordin and Daniel Morgan and Michael Mueller and Alba Guevara and Yuri Gordin",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2019",

year = "2019",

month = jan,

day = "1",

doi = "10.1007/978-3-030-12281-2\_25",

language = "English (US)",

isbn = "9783030122805",

pages = "205--216",

booktitle = "Deer's Treatment of Pain",

publisher = "Springer Science+Business Media",

}

TY - CHAP

T1 - Novel Analgesics

AU - Gordin, Vitaly

AU - Morgan, Daniel

AU - Mueller, Michael

AU - Guevara, Alba

AU - Gordin, Yuri

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Pain is the most frequent complaint and reason why patients visit medical providers. While opioid analgesics remain the mainstay of pain control in the acute setting, the benefits in chronic pain have been questioned. Overprescribing of opioid for acute and semi-acute pain has led to dependence in millions of Americans. It has been also responsible, at least partially, for opioid abuse and a closely related abuse of heroin. In the light of the current opioid epidemic, tremendous efforts have been made to develop new opioid ligands which are void of euphoric effects and medications whose action is targeting various pain mechanisms.

AB - Pain is the most frequent complaint and reason why patients visit medical providers. While opioid analgesics remain the mainstay of pain control in the acute setting, the benefits in chronic pain have been questioned. Overprescribing of opioid for acute and semi-acute pain has led to dependence in millions of Americans. It has been also responsible, at least partially, for opioid abuse and a closely related abuse of heroin. In the light of the current opioid epidemic, tremendous efforts have been made to develop new opioid ligands which are void of euphoric effects and medications whose action is targeting various pain mechanisms.

UR - https://www.scopus.com/pages/publications/105011793048

UR - https://www.scopus.com/pages/publications/105011793048#tab=citedBy

U2 - 10.1007/978-3-030-12281-2_25

DO - 10.1007/978-3-030-12281-2_25

M3 - Chapter

AN - SCOPUS:105011793048

SN - 9783030122805

SP - 205

EP - 216

BT - Deer's Treatment of Pain

PB - Springer Science+Business Media

ER -

Novel Analgesics

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this